Our data suggest that the TIM3/galectin-9 pathway might participate in the proceeding from obesity to T2DM, but the exact role of TIM3 in obesity-related T2DM needs to be further elucidated. This evidence concerns the gene HAVCR2 and type 2 diabetes mellitus.